Podcast
 |
| On this edition of The Burrill Report: Jim Greenwood, president and CEO of the Biotechnology Industry Organization, discusses the uncertainty surrounding healthcare reform, what it means for issues such as follow-on biologics, and what the industry's policy agenda looks like for 2010. |
G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release
Biotech Closes the Year on an Upswing January 04, 2010 | Press Release
Biotech gets back on track in November December 01, 2009 | Press Release
See all News
Daniel S. Levine
Web EditorThe Journal of Life Sciences
Prior to joining Burrill & Company in April 2007, Mr. Levine worked as special projects editor for the San Francisco Business Times where he won numerous awards for his coverage of the biotechnology industry. His work has appeared in the New York Times, The Industry Standard and theStreet.com as well as other national publications. He is the author of "Disgruntled: The Darker Side of the World of Work," (Berkley/Boulevard Books). Before he became a journalist, Danny served as a Vice President and General Principal with Herbert Young Securities in Great Neck, NY. He holds an AB in English from Vassar College and a Masters in Journalism from the University of California at Berkeley.